Results 151 to 160 of about 4,481,323 (329)

How to improve the sensitivity and specificity of cell-based assays in detecting autoantibodies in neuroimmune diseases. [PDF]

Ann Transl Med, 2023
Gao F, Zhang Y, Lv J, Wang S, He X, Liu P, Cui W.   +6 more
europepmc   +1 more source

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer

Molecular Oncology, EarlyView.
Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini, Ezgi Oner, Mark P. Ward, Sinead Hurley, Brian David Henderson, Faye Lewis, Stephen P. Finn, Gerard J. Fitzmaurice, John J. O'Leary, Sharon O'Toole, Lorraine O'Driscoll, Kathy Gately   +11 more
wiley   +1 more source

Cell-Based Assays to Identify Modulators of Nrf2/ARE Pathway. [PDF]

Methods Mol Biol, 2022
Wei Z, Zhao J, Zhang L, Xia M.
europepmc   +1 more source

Inhibition of Human Endogenous Retrovirus-K10 Protease in Cell-free and Cell-based Assays [PDF]

, 2001
Robert Kuhelj, Christopher J. Rizzo, Chong‐Hwan Chang, Prabhakar K. Jadhav, Eric M. Towler, Bruce D. Korant   +5 more
openalex   +1 more source

Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors

Molecular Oncology, EarlyView.
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi, Janelle‐Cheri Millen, Romela Irene Ramos, Jennifer A. Linehan, Timothy G. Wilson, Dave S. B. Hoon, Matias A. Bustos   +6 more
wiley   +1 more source

Protocol to study monocyte transmigration across primary human liver endothelial cells under physiological shear flow conditions in vitro

STAR Protocols
Summary: Modeling immune cell recruitment by liver endothelial cells in vitro is important to better understand the pathology of chronic inflammatory liver diseases and cancers.
Alex L. Wilkinson, Megan E. Bannister, Ayla O’Keeffe, Chris J. Weston, Patricia F. Lalor, Shishir Shetty, Daniel A. Patten   +6 more
doaj  

Pharmacologically active herbal remedies against atherosclerosis, characterization and DoE based marker quantification by densitometry, and cell based assays on THP-1 cell lines. [PDF]

Saudi Pharm J, 2023
Sireesha R, Krishnan M, Sadiq M, Ramanujam Ganesh M, Kamaraj C, Alharbi NS, Thiruvengadam M.   +6 more
europepmc   +1 more source

Flow cytometry-based assay for determination of teleost cytotoxic cell lysis of target cells [PDF]

, 2001
Mustapha Oumouna, Liliana Jaso‐Friedmann, Donald L. Evans   +2 more
openalex   +1 more source

KRAS and GNAS mutations in cell‐free DNA and in circulating epithelial cells in patients with intraductal papillary mucinous neoplasms—an observational pilot study

Molecular Oncology, EarlyView.
This study demonstrates that KRAS and GNAS mutations are more prevalent in patients with resected intraductal papillary mucinous neoplasms (IPMN) compared to those under clinical surveillance. GNAS mutations significantly differ between the two patient cohorts, indicating that their absence may serve as a potential biomarker to support conservative ...
Christine Nitschke, Marie Tölle, Philipp Walter, Kira Meißner, Mara Goetz, Jolanthe Kropidlowski, Andreas W. Berger, Jakob R. Izbicki, Felix Nickel, Thilo Hackert, Klaus Pantel, Harriet Wikman, Faik G. Uzunoglu   +12 more
wiley   +1 more source

Cell-Based Assays for Smoothened Ubiquitination and Sumoylation. [PDF]

Methods Mol Biol, 2022
Han Y, Jiang J.
europepmc   +1 more source